India
shares a major burden of oral and oropharyngeal cancers of the world. 1 Even with the major advances in the
surgical techniques and nonsurgical modalities such as various forms of radiotherapy,
chemotherapy and targeted therapy, overall outcome in terms of 5 year survival
remains at 56% in oral and oropharyngeal cancers.2 The prognosis is still worse in
Indian patients with high incidences of
p53 mutations.3 Delay in detection of these cases
is one of the prime reason for such outcomes. Cancers at other sites such as
cervix and breast do have better outcomes due to routine screening of early
stage lesions which are detected early of any developing malignant changes in
the lesion. Similar results of improved survivals are anticipated in a scenario
of detectable cyto-morphological changes that can be easily detected and
prognosticated4,5. This will help in detecting the
malignancies at an early stage, will reduce the overall disease burden and will
improve the overall treatment outcome of oral and oropharyngeal cancers.
Nuclear
and cytological markers of developing neoplastic transformations includes
morphological features including increased nuclear cytoplasmic ratios,
increased nuclear diameter and decreased cellular diameters; featured of
proliferative activity such as increased number of regions with affinity for
silver stains (AgNOR) and percentage of cells with >3 AgNOR avid regions;
and meta nuclear alterations including increased number of micronuclei, cells
with karyorrhexis and bi-nucleated cells. Micronucleus is a marker of
chromosomal damage, genome instability and carcinogenesis, integrating acquired
mutations and genetic susceptibility towards mutations.6,7 Possible role of identification of
such cytological nuclear features has been proven in buccal cells in literature
to identify DNA damage8 and in cases of buccal cancer4. However, there is still lack of
literature about its diagnostic and prognostic significance in premalignant
lesions where these can act as indicators of DNA damage and carcinogenesis for
early detection of developing malignancies. The prognostic significance of
cyto-morphologic nuclear and micro-nuclear changes in oral premalignant lesions
is also needed to be established.
Hence
we plan to conduct this study in order to see for various cytomorphologic and
nuclear changes in oral and oropharyngeal premalignant and malignant lesions,
to establish its diagnostic significance for early diagnosis and management in
premalignant lesions in developing malignancies and prognostic significance in
early malignant lesions of oral cavity and oropharynx. Methods:
The various method for studying
these nuclear and micro nuclear changes includes molecular biologic techniques
such as flow cytometry, FISH, routine stains, DNA specific stains, Fluorescent
stains and immune stains. Nonspecific routine stains include Giemsa, H & E,
Crystal violet, Azan and Papanicolaou etc. DNA specific stains include diamine
phenylindole (DAPI), Hoechst 33528, Ethidium Iodide/Bromide, Acridine Orange
and Propidium Iodide etc. Automation is possible in diamine phenylindole (DAPI),
Hoechst 33528, Ethidium Iodide/Bromide and Propidium Iodide. We intend to
include Acridine orange, Fuelgen, Papanicolaou, AgNOR and CK-8 antibodies in
cell blocks or standard histopathologic examinations of the identified patients
for our analysis. Post recruitment and consent
patients will be taken for definitive diagnosis and management as per the
routine departmental protocols and send for scrap cytology. The
smears hence collected will be Collection of exfoliated cells. Subjects will be
asked to rinse their mouth gently with tap water. To obtain the smear of
exfoliated cells from the oral cavity (buccal mucosa in control group), a
slightly moistened wooden spatula will be used. For pre malignant lesions
representative site selected will be areas of leucoplakia, erythroplakia &
oral sub mucous fibrosis in oral cavity and oropharynx. In OSCC patients, oral
mucosal cells will be scraped from the margins of the lesion for obtaining the
smear. The cells will be immediately smeared on pre cleaned microscopic slides.
Just prior to drying, the smears will be fixed with commercially available
spray fixative for 15 min. The
slides will be labelled and preserved in dust-free boxes until evaluation.
Biopsy & histopathological examination will be carried out in relevant
cases based upon cytopathological findings. Biopsy procedure
and histopathological gradingIncisional biopsies will be taken
from the representative sites with all aseptic precautions. The tissue specimen
will be labelled, fixed in 10% neutral buffered formalin for 24 h, and paraffin
embedded. The wax blocks will be cut to obtain two tissue sections of 4-5 μm
thickness for each block and the sections will be stained by haematoxylin and
eosin. Immunohistochemistry (CK8) will be performed on relevant cases.
Cytological preparation and evaluationThe smears will be stained by
Papanicolaou technique using a commercially available staining kit RAPIDPAP,
Feulgen stain, AgNOR stain & acridine orange. From each slide, 500 cells
will be examined under the light microscope using low magnification (×400) for
screening and high magnification (×1000) for counting of MN. Scoring criteriaThe criteria which was developed by
Tolbert et al. was used for counting the MN. Screening of each slide
was made in a zigzag manner from one end, toward the other end of the slide. Tolbert et al. criteria parameters for identifying
MN are as follows: 1. Rounded
smooth perimeter suggestive of a membrane. 2. Less
than a third the diameter of associated nucleus, but large enough to discern
shape and colour. 3. Staining
intensity similar to nucleus. 4. Same
focal plane as nucleus. 5. Texture
similar to nucleus. 6. The
absence of overlap with or bridge to the nucleus. Only those structures fulfilling the above-mentioned
criteria were recorded as MN. For
Silver avid regions we intend to calculate number of Ag avid regions and its
presence of absence. The
nuclear features and dimensions will be recorded using the standard software
available for calculating nuclear dimensions. Inclusion and exclusion criteria (Post-cytology)
Micronucleated cells will be counted out of 500 intact
epithelial cells, and they were expressed as percentages. Nuclear blebbing
(MN-like structure connected with the main nucleus with a bridge) are not
considered. Clumps of cells with obscured nuclear or cytoplasmic boundaries and
overlapping of cells are avoided and separated or cells lying singly are
preferred for counting of MN. Dead or degenerated cells, apoptotic cells, and
cytoplasmic fragments are excluded from evaluation.
|
Mile
stone
|
Targets
|
|
0-6
months
|
1. Sample collection.
2. Procurement of stains, antibodies and
detection kit.
|
|
7-18
months
|
1. Standardization of the staining & IHC
protocol
2. Prospective case analysis by staining
& IHC
|
|
19-24
months
|
Compilation
of data and submission along with knowledge outcome in terms of a paper.
|
Data analysis plan As per the requirement relevant
statistical data analysis will be performed using Independent Samples Test
(Student t test)/ chi square for comparison, Pearson’s and spearman’s
coefficients for correlation, multiple logistic regressions and ANNOVA of one
way, Friedman and kruswal wallis type as desired by the type of the data and
situation for multiple groups will be used. At the end a ROC curve will
be plot for the final scores to determine a threshold above which a definite
biopsy and referral can be planned for such lesions.
|